BlackRock’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$720M Buy
28,122,262
+3,492,391
+14% +$82.2M 0.01% 950
2026
Q1
$368M Sell
24,629,871
-264,855
-1% -$4.52M 0.01% 1303
2025
Q4
$362M Sell
24,894,726
-1,510,922
-6% -$26.3M 0.01% 1317
2025
Q3
$474M Buy
26,405,648
+2,916,511
+12% +$42.8M 0.01% 1133
2025
Q2
$401M Buy
23,489,137
+5,644,419
+32% +$56.5M 0.01% 1196
2025
Q1
$129M Buy
17,844,718
+128,622
+0.7% +$1.46M ﹤0.01% 1837
2024
Q4
$249M Buy
17,716,096
+2,168,405
+14% +$32M 0.01% 1544
2024
Q3
$184M Buy
15,547,691
+2,967,368
+24% +$30.7M ﹤0.01% 1710
2024
Q2
$117M Buy
12,580,323
+12,176,041
+3,012% +$62.2M ﹤0.01% 1934
2024
Q1
$1.43M Buy
+404,282
New +$1.4M ﹤0.01% 4104

Other funds holding CORZ

BlackRock's CORZ Position: Q2 2026 in Review

BlackRock increased its Core Scientific (CORZ) stake by 14% in Q2 2026, buying an estimated $82.2M and bringing the position to 28,122,262 shares worth $720M. The position accounts for 0.01% of the portfolio, ranked #950.

BlackRock first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • BlackRock held 28,122,262 shares of Core Scientific worth $720M as of Q2 2026.
  • BlackRock bought 3,492,391 Core Scientific shares in Q2 2026, an estimated $82.2M.
  • Core Scientific made up 0.01% of BlackRock's portfolio in Q2 2026, its #950 holding.
  • BlackRock first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.